Return to homepagePandemic Pact

to better understand how to utilize currently approved COVID-19 vaccines in people living with HIV in order to achieve the most potent and long-lived immune responses

Grant number: INV-046743

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2022

  • Known Financial Commitments (USD)

    $3,817,329

  • Funder

    Gates Foundation

  • Principal Investigator

    N/A

  • Research Location

    South Africa

  • Lead Research Institution

    Wits Health Consortium (Pty) Ltd

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Individuals with multimorbidityOther

  • Occupations of Interest

    Unspecified

Abstract

N/A

Publicationslinked via Europe PMC

Last Updated:43 minutes ago

View all publications at Europe PMC

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.